author-photo

Patrice Berthaud

Novartis

22

Papers

872

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Design and first interim analysis of a randomized phase III trial comparing imatinib versus imatinib (IM) based combination therapies in newly diagnosed chronic myelogenous leukemia patients in chronic phase

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study

2006 Leukemia
Show All
- Source
- Cite
- Save
Citations (108)
Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Quantification of Imatinib in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry: Applications to Therapeutic Drug Monitoring of Patients with Chronic Myelogenous Leukemia.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A Phase I/II Dose Escalating Study of Daunorubicin Combined with Imatinib Mesylate and Cytarabine as Induction Therapy for Chronic Myelogenous Leukaemia in Myeloid Blast Crisis. Preliminary Results of the AFR01 Trial.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (1)
P2-14 La prise en charge de la leucmie mylode chronique en France : Une tude transversale multic

2004 Revue D Epidemiologie Et De Sante Publique
Show All
- Source
- Cite
- Save
Citations (0)
Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data.

2004 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials☆☆☆

2003 Seminars in Hematology
Show All
- Source
- Cite
- Save
Citations (14)
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

2003 Blood
Show All
- Source
- Cite
- Save
Citations (61)
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo.

2003 Biochemical Pharmacology
Show All
- Source
- Cite
- Save
Citations (62)